Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe

We report two cases of dolutegravir (DTG) resistance in highly treatment experienced patients. Monitoring for treatment failure and adherence support is important in highly treatment experienced patients taking DTG. What this study adds: Dolutegravir is the mainstay of HIV treatment programmes and...

Full description

Bibliographic Details
Main Authors: Linda A. Mandikiyana Chirimuta, Margaret J. Pascoe, Sara Lowe
Format: Article
Language:English
Published: AOSIS 2022-10-01
Series:Southern African Journal of HIV Medicine
Subjects:
Online Access:https://sajhivmed.org.za/index.php/hivmed/article/view/1435